Evidence map›Paper›PMID 40098394›Full record

ArticleFuture microbiology2025

Not all disinfectants are created equal: the importance of mechanistic understanding to drive research forward.

Elise L Bezold, Kevin P C Minbiole, William M Wuest

Abstract readEditorial
In one paragraph

Article in Future microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Elise L BezoldDepartment of Chemistry, Emory University, Atlanta, GA, USA.
Kevin P C MinbioleDepartment of Chemistry, Villanova University, Villanova, PA, USA.
William M WuestDepartment of Chemistry, Emory University, Atlanta, GA, USA.

Funding

Natural Product-Inspired Approaches Toward The Development Of Antivirulence And Species-Specific InhibitorsR35GM119426 · NIGMS · TEMPLE UNIV OF THE COMMONWEALTH · PI William M Wuest · 2016 to 2026
$4.8M
The Development of Novel Disinfectants to Overcome Bacterial ResistanceR15AI185860 · NIAID · VILLANOVA UNIVERSITY · PI MINBIOLE, KEVIN P · 2024 to 2024
$359k
NIAID NIH HHS R15 AI185860NIGMS NIH HHS R35 GM119426
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antimicrobial resistancecationic biocidesDisinfectantsmembranesPseudomonas aeruginosaquaternary ammonium compoundsquaternary phosphonium compounds

Identifiers

PMID40098394
PMCPMC12001843

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.